Invention on Transcatheter Mitral Valve Replacement (Tmvr) Market Size & Forecasts (2016-2020)
- Submitted by: Marketreport
- Views: 63
- Category: Other
- Date Submitted: 08/09/2016 03:41 AM
- Pages: 3
- Report this Essay
Technavio Announces the Publication of its Research Report Global Transcatheter Mitral Valve Replacement Market 2016-2020
Technavio recognizes the following companies as the key players in the global transcatheter mitral valve replacement market: Abbott Laboratories, Edwards Lifesciences, Micro Interventional Devices, and Neovasc.
Other Prominent Vendors in the market are MitrAssist, NaviGate Cardiac Structures, and Valtech.
Commenting on the report, an analyst from Technavios team said that the development of novel products will promote growth for this market. Advances in technology, material, and design of prosthetic valves and delivery devices have led surgeons to perform mitral valve replacement procedures with better post-surgical outcomes. The growing focus on compatibility and durability of implants in the human body led cardiologists to prefer transcatheter mitral valves to mechanical prosthetic valves. The shift from open-heart procedures to minimally invasive methods for the implantation of devices since 2005 has been a breakthrough in the demand and sales of heart valves.
Browse full report with TOC@ https://marketreportscenter.com/reports/344097/global-transcatheter-mitral-valve-replacement-market-2016-2020
According to the report, prevalence of mitral regurgitation is one of the drivers that led to the growth of this market. Mitral regurgitation is a common heart valve disorder that affects 2%-3% of the population worldwide. The disorder is becoming prevalent among all age groups rapidly. About 0.5% of individuals aged 18-45 and 9% of people aged 60-75 have this disorder. In 2009, research studies estimated that more than 176 million people worldwide have the disorder. These studies also estimated that more than four million individuals in the US had mitral regurgitation. Of this number, about one in 10 individuals was aged 75 and above.
Further, the report states that availability of alternative treatment is negatively affecting the...
Technavio recognizes the following companies as the key players in the global transcatheter mitral valve replacement market: Abbott Laboratories, Edwards Lifesciences, Micro Interventional Devices, and Neovasc.
Other Prominent Vendors in the market are MitrAssist, NaviGate Cardiac Structures, and Valtech.
Commenting on the report, an analyst from Technavios team said that the development of novel products will promote growth for this market. Advances in technology, material, and design of prosthetic valves and delivery devices have led surgeons to perform mitral valve replacement procedures with better post-surgical outcomes. The growing focus on compatibility and durability of implants in the human body led cardiologists to prefer transcatheter mitral valves to mechanical prosthetic valves. The shift from open-heart procedures to minimally invasive methods for the implantation of devices since 2005 has been a breakthrough in the demand and sales of heart valves.
Browse full report with TOC@ https://marketreportscenter.com/reports/344097/global-transcatheter-mitral-valve-replacement-market-2016-2020
According to the report, prevalence of mitral regurgitation is one of the drivers that led to the growth of this market. Mitral regurgitation is a common heart valve disorder that affects 2%-3% of the population worldwide. The disorder is becoming prevalent among all age groups rapidly. About 0.5% of individuals aged 18-45 and 9% of people aged 60-75 have this disorder. In 2009, research studies estimated that more than 176 million people worldwide have the disorder. These studies also estimated that more than four million individuals in the US had mitral regurgitation. Of this number, about one in 10 individuals was aged 75 and above.
Further, the report states that availability of alternative treatment is negatively affecting the...